Literature DB >> 29666687

Efficacy of OK-432 Therapy for the Incisionless Treatment of Head and Neck Cystic Masses: Case series.

Hesham Y A Hasan1, Muhammad A Rizwan1.   

Abstract

Head and neck masses can present in different pathologies that usually vary according to the age of the patient. We report five cases of benign head or neck masses occurring among patients of different ages who were managed at the Bahrain Defence Force Royal Medical Services Hospital, Ar-Rifaa, Bahrain, between 2005-2014. All of the patients were treated using the sclerotherapeutic agent OK-432. Although surgical removal is usually considered optimal treatment in the management of such cases, OK-432 appears to be a promising alternative.

Entities:  

Keywords:  Bahrain; Branchial Cyst; Case Series; Cystic Hygroma; Lymphatic Abnormalities; OK-432; Sclerotherapy; Thyroglossal Cyst

Mesh:

Substances:

Year:  2018        PMID: 29666687      PMCID: PMC5892819          DOI: 10.18295/squmj.2018.18.01.014

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  24 in total

1.  Effects and mechanism of OK-432 therapy in various neck cystic lesions.

Authors:  Nobuo Ohta; Shigeru Fukase; Tomoo Watanabe; Tsukasa Ito; Masaru Aoyagi
Journal:  Acta Otolaryngol       Date:  2010-11       Impact factor: 1.494

2.  Presentation, Management, and Outcome of Thyroglossal Duct Cysts in Adult and Pediatric Populations: A 14-Year Single Center Experience.

Authors:  Hassan Al-Thani; Ayman El-Menyar; Maryam Al Sulaiti; Jamela El-Mabrok; Khairi Hajaji; Hesham Elgohary; Mohammad Asim; Ibrahim Taha; Abdelhakem Tabeb
Journal:  Oman Med J       Date:  2016-07

3.  Surgery for thyroglossal duct and branchial cleft anomalies.

Authors:  S A Deane; R L Telander
Journal:  Am J Surg       Date:  1978-09       Impact factor: 2.565

4.  Treatment of branchial cleft cyst with intracystic injection of OK-432.

Authors:  Jong-Lyel Roh; Myung-Whun Sung; Kwang Hyun Kim; Chan Il Park
Journal:  Acta Otolaryngol       Date:  2006-05       Impact factor: 1.494

5.  Postoperative adjuvant OK-432 sclerotherapy for treatment of cervicofacial lymphatic malformations: an outcomes comparison.

Authors:  So Young Kim; Sanghoon Lee; Jeong-Meen Seo; So Young Lim
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2015-02-07       Impact factor: 1.675

Review 6.  HIV-associated salivary gland disease.

Authors:  Rabie M Shanti; Shahid R Aziz
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2009-08       Impact factor: 2.802

7.  Comparative analysis of intralesional sclerotherapy with sodium tetradecyl sulfate versus bleomycin in the management of low flow craniofacial soft tissue vascular lesions.

Authors:  Hemant Bajpai; Sarika Bajpai
Journal:  J Maxillofac Oral Surg       Date:  2011-12-28

8.  Sclerotherapy of branchial cleft cysts using OK-432.

Authors:  Myung-Gu Kim; No-Hee Lee; Jae-Ho Ban; Kyung-Chul Lee; Sung-Min Jin; Sang-Hyuk Lee
Journal:  Otolaryngol Head Neck Surg       Date:  2009-09       Impact factor: 3.497

9.  Induction of inflammatory cytokines in effusion cavity by OK-432 injection therapy for patients with malignant effusion: role of interferon-gamma in enhancement of surface expression of ICAM-1 on tumor cells in vivo.

Authors:  H Kitsuki; M Katano; A Ikubo; T Morisaki; K Anann; M Tanaka; M Torisu
Journal:  Clin Immunol Immunopathol       Date:  1996-03

10.  The therapeutic effect of OK-432 (picibanil) sclerotherapy for benign neck cysts.

Authors:  Myung Gu Kim; Sun Gon Kim; Jun Ho Lee; Young Gyu Eun; Seung Geun Yeo
Journal:  Laryngoscope       Date:  2008-12       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.